Playback speed
10 seconds
AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients With High Cardiovascular Risk and Elevated Low-Density Lipoprotein Cholesterol (ORION-3)
By
AHA 2022 Conference Coverage
FEATURING
Kausik Ray
By
AHA 2022 Conference Coverage
FEATURING
Kausik Ray
0 views
November 30, 2022
Comments 7
Login to view comments.
Click here to Login